XML 34 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
STOCK-BASED COMPENSATION (Tables)
 9 Months Ended
Nov. 03, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of stock-based compensation

A summary of the Company’s stock-based compensation (a component of selling, general and administrative expenses) and related income tax benefit is as follows:

 

    Thirteen Weeks Ended     Thirty Nine Weeks Ended  
(in thousands)   November 3, 2018     October 28, 2017     November 3, 2018     October 28, 2017  
Continuing Operations                                
Stock option expense   $ 215     $ 307     $ 709     $ 1,152  
Restricted stock expense     226       1,059       1,976       3,026  
ESPP expense     —       244       —       428  
Total stock-based compensation   $ 441     $ 1,610     $ 2,685     $ 4,606  
                                 
Income tax benefit on stock-based compensation   $ 11     $ 414     $ 34     $ 1,192  

 

    Thirteen Weeks Ended     Thirty Nine Weeks Ended  
(in thousands)   November 3, 2018     October 28, 2017     November 3, 2018     October 28, 2017  
Discontinued Operations                                
Stock option expense   $ 13     $ 50     $ 48     $ 174  
Restricted stock expense     9       15       34       63  
Total stock-based compensation   $ 22     $ 65     $ 82     $ 237  
                                 
Income tax benefit on stock-based compensation   $ —     $ —     $ 4     $ 14  
Schedule of stock option granted using the Black-Scholes option-pricing model

The fair value of each option granted during the thirteen and thirty-nine week periods ended November 3, 2018 and October 28, 2017 is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions: 

 

    Thirteen Weeks Ended     Thirty Nine Weeks Ended  
Continuing Operations   November 3, 2018     October 28, 2017     November 3, 2018     October 28, 2017  
Stock Options                                
Expected volatility     0.0 %     46.1 %     0.0 %     41.7 %
Risk-free interest rate     0.0 %     1.9 %     0.0 %     2.1 %
Expected option life (in years)     0       5.84       0       5.84  
Expected dividend yield     0.00 %     1.98 %     0.00 %     1.87 %
                                 
Weighted average fair value at grant date   $ —     $ 2.44     $ —     $ 4.11  

 

    Thirteen Weeks Ended     Thirty Nine Weeks Ended  
Discontinued Operations   November 3, 2018     October 28, 2017     November 3, 2018     October 28, 2017  
Stock Options                                
Expected volatility     0.0 %     0.0 %     0.0 %     43.1 %
Risk-free interest rate     0.0 %     0.0 %     0.0 %     2.2 %
Expected option life (in years)     0       0       0       5.84  
Expected dividend yield     0.00 %     0.00 %     0.00 %     1.85 %
                                 
Weighted average fair value at grant date   $ —     $ —     $ —     $ 4.89  

 

    Thirteen Weeks Ended     Thirty Nine Weeks Ended  
    November 3, 2018     October 28, 2017     November 3, 2018     October 28, 2017  
                         
Employee Stock Purchase Plan                                
Expected volatility     0.0 %     86.1 %     0.0 %     82.2 %
Risk-free interest rate     0.0 %     1.0 %     0.0 %     1.0 %
Expected option life (in years)     0.00       0.75       0.00       0.50  
Expected dividend yield     0.00 %     1.24 %     0.00 %     0.81 %
                                 
Weighted average fair value at grant date   $ —     $ 7.95     $ —     $ 6.86
Schedule of stock option activity

The following table summarizes stock option activity during the thirty-nine weeks ended November 3, 2018:  

 

Continuing Operations   Options     Weighted- Average Exercise Price     Weighted-Average Contractual Life (years)     Aggregate Intrinsic Value (000s)  
                         
Outstanding at February 3, 2018     1,171,825     $ 13.12       5.1     $ —  
Granted     —       —                  
Cancelled     (537,254 )     12.29                  
Exercised     —       —                  
Outstanding at November 3, 2018     634,571     $ 13.83       4.4     $ —  
                                 
Exercisable at November 3, 2018     442,605     $ 14.60       4.2       —  

 

Discontinued Operations   Options     Weighted- Average Exercise Price     Weighted-Average Contractual Life (years)     Aggregate Intrinsic Value (000s)  
                         
Outstanding at February 3, 2018     167,375     $ 14.23       5.4     $ —  
Granted     —       —                  
Cancelled     (158,984 )     14.17                  
Exercised     —       —                  
Outstanding at November 3, 2018     8,391     $ 15.44       4.5     $ —  
                                 
Exercisable at November 3, 2018     3,356     $ 15.44       4.5     $ —
Schedule of restricted stock activity

The following table summarizes restricted stock activity during the thirty-nine weeks ended November 3, 2018:  

 

Continuing Operations   Number of Shares     Weighted-Average Grant Date Fair Value  
             
Non-vested Restricted Stock at February 3, 2018     653,895     $ 10.14  
Granted     649,233       2.23  
Forfeited / Cancelled     (109,512 )     10.68  
Vested     (413,630 )     7.73  
Non-vested Restricted Stock at November 3, 2018     779,986     $ 4.77  

 

Discontinued Operations   Number of Shares     Weighted-Average Grant Date Fair Value  
             
Non-vested Restricted Stock at February 3, 2018     11,194     $ 15.35  
Granted     —       —  
Forfeited / Cancelled     (8,862 )     14.95  
Vested     (2,332 )     15.44  
Non-vested Restricted Stock at November 3, 2018     —     $ —